United Advisor Group »

Recursion Pharmaceuticals shares owned by United Advisor Group

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by United Advisor Group from 13F filings

Historical chart of United Advisor Group investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by United Advisor Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by United Advisor Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8k 600 3.07

More positions owned by United Advisor Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ea Series Trust Strive 500 Etf (STRV)
Amazon Call Option (AMZN)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Microsoft Corporation Call Option (MSFT)
Palantir Technologies Cl A (PLTR)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Wisdomtree Tr Us Largecap Divd (DLN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Spdr Series Trust State Street Spd (SPYG)
T Rowe Price Etf Price Div Grwt (TDVG)

View all positions for United Advisor Group

Top funds holding Recursion Pharmaceuticals

Vanguard Group
BlackRock
ARK Investment Management
State Street Corporation
Baillie Gifford & Co
Softbank Group Corp
Geode Capital Management
MIC Capital Management UK
Susquehanna International
Citadel Advisors
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Data Collective IV GP
Norges Bank Investment Management
Exor Investments

View all funds holding Recursion Pharmaceuticals